CRIS Current Research Information System

CAPPELLINI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.815
AS - Asia 3.519
EU - Europa 2.818
AF - Africa 212
SA - Sud America 198
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.568
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.779
VN - Vietnam 1.081
SG - Singapore 1.002
CN - Cina 729
IT - Italia 586
GB - Regno Unito 583
SE - Svezia 406
DE - Germania 364
HK - Hong Kong 266
FR - Francia 157
IN - India 155
BR - Brasile 137
RU - Federazione Russa 123
IE - Irlanda 99
NL - Olanda 90
UA - Ucraina 90
FI - Finlandia 84
ZA - Sudafrica 70
TG - Togo 52
JP - Giappone 50
EE - Estonia 46
CI - Costa d'Avorio 37
JO - Giordania 37
BG - Bulgaria 34
CH - Svizzera 34
AR - Argentina 28
AT - Austria 26
SC - Seychelles 25
BE - Belgio 24
KR - Corea 23
BD - Bangladesh 22
PH - Filippine 22
CA - Canada 20
PL - Polonia 20
ID - Indonesia 19
TH - Thailandia 15
TW - Taiwan 15
MX - Messico 13
TR - Turchia 13
EC - Ecuador 11
NG - Nigeria 11
PK - Pakistan 11
HR - Croazia 10
IQ - Iraq 10
IR - Iran 9
SA - Arabia Saudita 8
ES - Italia 7
UZ - Uzbekistan 7
CL - Cile 6
CZ - Repubblica Ceca 6
GR - Grecia 6
PY - Paraguay 5
DZ - Algeria 4
LT - Lituania 4
PT - Portogallo 4
AU - Australia 3
CO - Colombia 3
IL - Israele 3
KE - Kenya 3
LB - Libano 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EG - Egitto 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.568
Salva come PNG Salva come JPEG
Città #
Singapore 709
Southend 481
Ashburn 396
Chandler 307
Fairfield 271
Hong Kong 258
Santa Clara 230
Ho Chi Minh City 214
Hanoi 197
Houston 197
Ann Arbor 194
San Jose 180
Bologna 179
Woodbridge 162
Dong Ket 150
Seattle 149
Wilmington 130
Princeton 110
Beijing 105
Dublin 99
Cambridge 96
Boardman 89
Helsinki 71
Dallas 66
New York 63
Hefei 56
Lauterbourg 53
Lomé 52
Nanjing 52
Padova 51
Los Angeles 50
Westminster 50
Jacksonville 49
Frankfurt am Main 39
Abidjan 37
Amman 37
Council Bluffs 35
Tokyo 35
Sofia 34
Berlin 33
Da Nang 32
Bern 30
Shenyang 29
Redmond 28
Bremen 27
Haiphong 27
Johannesburg 26
Milan 25
Saint Petersburg 25
Turin 24
Brussels 23
Buffalo 23
Guangzhou 23
Redondo Beach 23
Munich 22
San Diego 22
Changsha 21
Florence 19
Jinan 19
São Paulo 19
Orem 18
Tianjin 18
Vienna 18
Seoul 17
Moscow 16
Nanchang 15
Ninh Bình 15
Shanghai 15
The Dalles 15
Falkenstein 14
Hangzhou 14
Hebei 14
Warsaw 14
Atlanta 13
London 13
Rome 13
Biên Hòa 12
Des Moines 12
Medford 12
Zhengzhou 12
Abeokuta 11
Amsterdam 11
Chicago 11
Falls Church 11
Jakarta 11
Redwood City 11
Verona 11
Mülheim 10
Norwalk 10
Can Tho 9
Ferrara 9
Nuremberg 9
Parma 9
Phoenix 9
Quận Bình Thạnh 9
San Francisco 9
Düsseldorf 8
Nha Trang 8
Ningbo 8
Reggio Emilia 8
Totale 6.735
Salva come PNG Salva come JPEG
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 343
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 281
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 269
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 258
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 219
Therapeutic targeting of CK2 in acute and chronic leukemias. 218
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 208
Specific presence of PKC isoforms in low and fast proliferation Moris hepatoma cells 207
Effect of PKC inhibition on low and fast proliferating Morris rat hepatoma cell line progression 204
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 204
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 203
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 203
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 197
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 197
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 196
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 195
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 193
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 189
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 188
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 183
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 182
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 180
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 177
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 176
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 174
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. 173
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 171
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 170
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 165
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 165
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 164
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 162
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 161
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 158
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 158
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 158
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 156
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 155
Metabolism and signaling activities of nuclear lipids 154
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 154
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells 153
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 151
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 149
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 145
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation 144
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 142
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression 139
Improving nelarabine efficacy in refractory/relapsed T-cell Acute Lymphoblastic Leukemia by targeting aberrant PI3K/mTOR signaling 138
PKC inhibitors induced apoptosis in Morris hepatoma 136
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 133
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 132
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 119
SELECTIVE EFFECT OF LENALIDOMIDE ON CELL CYCLE AND INOSITIDE-DEPENDENT ERYTHROID SIGNALLING IN DEL(5Q) CELLS AND MYELODYSPLASTIC SYNDROMES (MDS) 119
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways 118
Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 111
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 98
null 95
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 93
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 93
Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood 90
Non-selective beta-blockers enhance resolution of induced infections in animals and healthcare-associated infections in humans 85
Flow cytometric detection of total and serine 473 phosphorylated Akt 64
Diacylglycerol kinase-θ is localized in the speckle domains of the nucleus 63
Molecular characterization of protein kinase C‐α binding to lamin A 62
Intranucleolar localization of DNA topoisomerase IIα is a distinctive feature of necrotic, but not of apoptotic, Jurkat T‐cells 60
HIV-1 Tat Protects CD4+ Jurkat T Lymphoblastoid Cells from Apoptosis Mediated by TNF-Related Apoptosis-Inducing Ligand 54
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells 50
The controversial nuclear matrix: a balanced point of view 49
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression 45
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-κB activation and cFLIPL up-regulation 43
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 40
Totale 10.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 0 0 0 0 45 46 329
2021/20221.360 154 17 95 125 108 67 51 87 43 225 218 170
2022/20231.283 112 171 65 179 104 117 58 63 227 17 96 74
2023/2024482 35 52 38 41 32 121 19 46 24 29 22 23
2024/20251.462 42 180 138 78 328 81 89 56 23 106 51 290
2025/20263.434 256 411 308 201 486 258 394 144 726 250 0 0
Totale 10.781